"For the time period between November 1, 2023, and October 31, 2024, which is the time period used to determine which drugs were eligible for negotiation for this second cycle, about 5.3 million people with Medicare Part D coverage used these drugs to treat a variety of conditions, such as cancer, type 2 diabetes, and asthma," the CMS fact sheet states
Weight loss goals, tolerance for adverse effects, and budget influence your final choice
Due to the shortage of prescription weight-loss medications this year, patients often have to spend time looking for the drugstime that typically isnt afforded to lower-paid frontline workers in less flexible work environments
Daily weight (looking at weekly averages, not daily fluctuations), weekly photos, and body measurements provide objective data that cuts through the subjective experience of "I do not feel like it is working." Many people are visibly losing fat and improving body composition even when the scale is temporarily stalled
The maximum dose of Trulicity is 4.5 mg
